Here we describe a retrospective chart review of 26 unique LMD breast cancer patients treated at Northwestern University and University of Texas Southwestern Medical Center, in whom CNSide testing was utilized to analyze CSF for tumor cell number and HER2 status. This evidence concerns the gene ERBB2 and breast carcinoma.